SCHEMBL17599504

SCHEMBL17599504

Cn1ccc2c(S(=O)(=O)Nc3ccc(N4CC[C@@H](C(=O)O)C4)c4ncccc34)cccc21

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 7/20 0.65
▸ NFE2L2 Q16236 1/20 0.49
▸ BRD4 O60885 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ BRAF P15056 1/20 0.39
▸ MMP2 P08253 1/20 0.38
▸ CCR10 P46092 1/20 0.37
▸ PRKCA P17252 1/20 0.37
▸ PRKCQ Q04759 1/20 0.37
▸ SLC40A1 Q9NP59 1/20 0.37
▸ UQCRB P14927 1/20 0.37
▸ DRD2 P14416 2/20 0.37
▸ HTR2A P28223 2/20 0.37
▸ HTR7 P34969 2/20 0.37
▸ HTR6 P50406 2/20 0.37
▸ PKLR P30613 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599501 0.88 KEAP1 (0.62) KEAP1NFE2L2BRD4CCR10DRD2
SCHEMBL17599448 0.81 KEAP1 (0.73) KEAP1NFE2L2KDM4EMMP2SLC40A1
SCHEMBL17599495 0.81 KEAP1 (0.63) KEAP1NFE2L2BRD4KDM4EMMP2
SCHEMBL17599418 0.79 KEAP1 (1.00) KEAP1NFE2L2KDM4EMMP2SLC40A1
SCHEMBL17612884 0.79 KEAP1 (1.00) KEAP1NFE2L2KDM4EMMP2SLC40A1
SCHEMBL17599451 0.79 KEAP1 (1.00) KEAP1NFE2L2KDM4EMMP2SLC40A1
SCHEMBL17599497 0.77 KEAP1 (0.75) KEAP1NFE2L2KDM4EMMP2SLC40A1
SCHEMBL17599461 0.74 KEAP1 (0.65) KEAP1NFE2L2KDM4EMMP2SLC40A1
SCHEMBL17599439 0.74 KEAP1 (0.90) KEAP1NFE2L2KDM4EMMP2SLC40A1
SCHEMBL17599464 0.73 KEAP1 (0.66) KEAP1NFE2L2BRD4KDM4EMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997966-A1 Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback